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Introduction
The crucial regulators of commitment to apoptotic cell death in 
mammals include three subclasses of the Bcl-2 family of pro-
teins, each characterized by the presence of one or more Bcl-2 
homology (BH) domains (Newmeyer and Ferguson-Miller, 
2003; Danial and Korsmeyer, 2004; Adams and Cory, 2007). 
The prosurvival (or antiapoptotic) proteins, which contain three 
or four of the BH domains, are represented by Bcl-2, Bcl-xL, 
Bcl-w, Mcl-1, and A1. The proapoptotic BH3-only members, 
which act as sensors of specifi  c types of cellular stress, include 
Bid, Bim, Puma, Bad, Noxa, Bmf, Hrk, and Bik (Willis and 
Adams, 2005). Acting downstream of both of these groups are the 
proapoptotic multidomain proteins, which contain BH1–3 and 
are represented by Bax, Bak, and perhaps Bok (Lindsten et al., 
2000; Wei et al., 2001). Once activated, Bax and Bak mediate 
permeability of the mitochondrial outer membrane, releasing 
proapoptotic factors, particularly cytochrome c, that provoke 
caspase activation and the resulting rapid packaging of cell 
fragments for removal (Green, 2005). Although either Bax or 
Bak is required for apoptosis, their localization in healthy cells 
differs: Bak is an integral protein of the mitochondrial outer 
membrane, whereas Bax is predominantly cytosolic or loosely 
attached to the mitochondrial outer membrane.
Commitment to apoptosis is governed by interactions be-
tween members of the Bcl-2 subclasses mediated by the amphi-
pathic α-helical BH3 domain. Structural studies have revealed that 
BH3 peptides from Bak and Bad as well as the Bim polypeptide 
behave like ligands in binding to a hydrophobic groove on the sur-
face of Bcl-xL (Sattler et al., 1997; Liu et al., 2003). Indeed, BH3 
peptides derived from each of the BH3-only proteins can mimic 
their full-length parent polypeptides in binding to prosurvival pro-
teins, permeabilizing isolated mitochondria, and inducing apopto-
sis (Letai et al., 2002; Chen et al., 2005; Kuwana et al., 2005).
The interactions between Bcl-2 family members that allow 
the critical step of Bax and Bak activation remain poorly under-
stood (Willis and Adams, 2005). One widely discussed model 
posits that a subclass of BH3-only proteins termed activators, 
which are proposed to include Bim and Bid (after its truncation 
by caspases; Letai et al., 2002; Kuwana et al., 2005; Certo et al., 
2006) and perhaps Puma (Cartron et al., 2004), can bind not only 
to the prosurvival proteins but also to Bax and Bak and provoke 
their activation. On this direct activation model (Fig. 1 A, left), 
the remaining BH3-only proteins, which are termed sensitizers, 
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simply bind to the prosurvival proteins, lowering their capacity to 
sequester the activators. However, important aspects of this model 
remain problematic (see Discussion; Willis and Adams, 2005).
An alternative view promoted by recent fi  ndings  (Chen 
et al., 2005; Willis et al., 2005, 2007) is that the BH3-only proteins 
exclusively engage the prosurvival proteins, overcoming their 
  sequestration of Bak or Bax (Fig. 1 A, right). Pertinent to this indi-
rect activation model, certain BH3-only proteins interact selectively 
with subsets of the prosurvival proteins (Fig. 1 B): whereas Bim 
and Puma bound all fi  ve tightly, Noxa instead bound only Mcl-1 
and A1, whereas Bad engaged only Bcl-2, Bcl-xL, and Bcl-w 
(Chen et al., 2005). Importantly, neutralization of multiple prosur-
vival proteins was required to induce apoptosis (Chen et al., 2005). 
Furthermore, only certain prosurvival proteins engage Bak (Fig. 
1 B): in healthy fi  broblasts, both Mcl-1 and Bcl-xL but not Bcl-2 
could bind Bak and protect against Bak-mediated permeability 
(Willis et al., 2005). In accord with the indirect activation model, 
Bak was freed by BH3-only proteins that bind tightly to both Mcl-1 
and Bcl-xL, such as Noxa plus Bad (Willis et al., 2005).
Thus, whether the BH3-only proteins activate Bak and 
Bax directly or indirectly (or both) remains to be established 
(Willis and Adams, 2005). Because the Bcl-2 family primarily 
regulates the integrity of the mitochondrial outer membrane, 
it is essential to establish which interactions between its sub-
classes directly control mitochondrial permeability. In this 
study, we have explored whether the previously identifi  ed inter-
actions of prosurvival proteins with Bak or those with BH3 pep-
tides from BH3-only proteins (Chen et al., 2005; Willis et al., 
2005) can account for their ability to regulate mitochondrial 
permeability. Cytochrome c release was assessed on two sources 
of mitochondria: those from Xenopus laevis eggs (Xenopus egg 
mitochondria [XEM]) were chosen because they are particu-
larly robust and their permeabilization has been widely studied 
(Kluck et al., 1999; von Ahsen et al., 2000; Kuwana et al., 2002; 
Nutt et al., 2005), whereas mouse liver mitochondria (MLM) 
were selected because they lack Bax and thus exhibit Bak-
dependent permeabilization (Letai et al., 2002). We analyze our 
results both from the perspective of how prosurvival proteins 
prevent permeabilization and how BH3-only proteins act to per-
meabilize mitochondria. In accord with the indirect activation 
model, the fi  ndings indicate that prosurvival proteins act by 
  interacting with mitochondrial components such as Bak (and 
perhaps Bax) and that BH3-only proteins must engage multiple 
prosurvival proteins to induce effi  cient permeabilization.
Results
Most BH3 peptides can permeabilize 
mitochondria isolated from mouse liver 
and Xenopus eggs
To explore whether selective binding of BH3-only domains 
to prosurvival proteins could regulate mitochondrial integrity, 
we fi  rst established whether each of eight BH3 peptides could 
permeabilize mitochondria. We used long BH3 peptides 
(24–26 mers) with known affi  nities for the prosurvival proteins 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200606065/DC1; Chen et al., 2005). When MLM were incu-
bated with each peptide for 2 h at 37°C, specifi  city was observed 
in that most of the peptides (Puma, Bmf, Bid, Bik, Bad, Hrk, 
and Bim), if added at 10 μm, promoted Bak oligomerization 
and cytochrome c release, whereas the human NoxaBH3 was 
inactive (Fig. 1 C and Fig. S2), as were peptides from both the 
BH3 domains of mouse Noxa (not depicted). The BH3 peptides 
exhibited similar specifi  city on XEM after a 2-h incubation at 
room temperature, although certain ones were up to 10-fold 
more active (Fig. 1 C). Notably, under our conditions, several 
BH3 peptides termed sensitizers (Puma, Bmf, Bik, Bad, and 
Hrk) promoted cytochrome c release essentially as effectively 
as the putative activators Bid and Bim (see Discussion).
Each of the BH3 peptides active in this assay exhibits high 
affi  nity for Bcl-xL and Bcl-w, whereas the only inactive peptide, 
Noxa, binds only to Mcl-1 and A1 (Figs. 1 B and S1 B; Chen 
et al., 2005; Willis et al., 2005). This suggests that the endogenous 
prosurvival proteins protecting both XEM and MLM are princi-
pally Bcl-xL–like rather than Mcl-1–like. Indeed, by Western 
blot analysis, MLM contained readily detectable levels of Bcl-xL, 
albeit undetectable Bcl-2, Bcl-w, or A1 and very little Mcl-1 
(Fig. 1 D and Fig. S3, A–C; available at http://www.jcb.org/cgi/
content/full/jcb.200606065/DC1). Nevertheless, even these low 
levels of Mcl-1 seem to be functionally relevant because the 
Bad peptide, which does not bind Mcl-1 or A1, gave a less com-
plete permeabilization of MLM than the Bim or Bid BH3 pep-
tides. For the XEM, appropriate antibodies are not yet available 
for determining which of the fi  ve known Xenopus prosurvival 
homologues (Aouacheria et al., 2005) are present, but Bcl-xL–
like proteins probably predominate because BadBH3 but not 
NoxaBH3 permeabilized the XEM.
Importantly, the permeabilizing activities of Bim and Nox-
aBH3 peptides were altered by mutations known to affect both 
their binding to prosurvival molecules and their proapoptotic 
  activities. Thus, BimBH3 mutated at either a single invariant 
residue (L94A) or, at four conserved residues (4E: I89E, L94E, 
I97E, and F101E), no longer permeabilized XEM (Fig. 1 E) or 
MLM (not depicted). These mutations decrease binding to pro-
survival proteins at least 50-fold and abrogate proapoptotic 
activity in mouse embryonic fi  broblasts (Hinds et al., 2003; 
Wilson-Annan et al., 2003; Chen et al., 2005). Conversely, in the 
case of NoxaBH3, we previously showed that single (K35E or 
F32I) or double (K35E/F32I) mutations markedly increase bind-
ing to Bcl-xL–like prosurvival proteins as well as proapoptotic 
activity (Fig. S1; Chen et al., 2005). Accordingly, the mutant 
peptides, unlike the wild-type NoxaBH3, could permeabilize 
both XEM and MLM (Fig. 1 F). Thus, both ablating the ability 
of Bim BH3 to bind prosurvival proteins and extending the range 
bound by NoxaBH3 have effects on mitochondrial permeability 
that parallel their known proapoptotic activities in cells. These 
fi  ndings argue that the ability to engage specifi  c subsets of pro-
survival proteins determines both the mitochondrial permeabi-
lizing activity and proapoptotic behavior of BH3-only proteins.
The permeabilization of MLM 
is temperature dependent
A recent study (Certo et al., 2006) reported results with MLM 
that differ in important respects from those shown in Fig. 1 C. BCL-2 PROTEIN INTERACTIONS AT MITOCHONDRIA • UREN ET AL.  279
Figure 1. Speciﬁ  city of BH3 peptide–induced cytochrome c release. (A) Prosurvival proteins are proposed to block mitochondrial permeability by sequester-
ing BH3-only proteins (direct activation model) or primarily Bax/Bak proteins (indirect activation model). (B) Previously identiﬁ  ed speciﬁ  c interactions 
between members of each Bcl-2 subfamily (Fig. S1 B, available at http://www.jcb.org/cgi/content/full/jcb.200606065/DC1; Chen et al., 2005). 
(C) Selective permeabilization by BH3 peptides. Mitochondria isolated from mouse liver or from Xenopus eggs were incubated for 2 h at 37 (mouse liver) or 
22°C (Xenopus) with peptides derived from the BH3 domains of BH3-only proteins. Equivalent volumes of supernatant (S/N) and mitochondrial pellet (Mito) 
were then analyzed for cytochrome c by Western blotting. The sequence of each peptide is from the human protein sequence (Fig. S1 A) except for Bmf 
(from mouse) and Bad (human in top panel and mouse in bottom panel). BH3 peptides derived from mouse and human Bad were equivalent in permeabiliz-
ing and binding activity (not depicted) and were used interchangeably. (D) Bcl-xL and traces of Mcl-1 are present in MLM. Bcl-xL and Mcl-1 levels in MLM 
and mouse embryonic ﬁ  broblasts (MEFs) were compared by Western blotting. 0.7 pmol of recombinant Bcl-xL and 0.25 pmol Mcl-1 were included where 
indicated. Positions of molecular weight markers are indicated. The asterisk denotes a band in MLM that aligns with the bottom band of the Mcl-1 doublet 
in the mouse embryonic ﬁ  broblast. Reprobing the blots for cytochrome c (bottom) provides a comparison of the mitochondrial content of each sample. 
(E) Mutant Bim peptides lose permeabilizing activity. Mouse BimBH3 peptides with mutations at one (L94A) or four (4E; I89E, L94E, I97E, and F101E) con-
served residues were compared with wild-type (wt) peptide for the ability to permeabilize XEM as in C (residue number refers to the mBimL protein). Equiva-
lent results were found with MLM (not depicted). (F) Mutated Noxa peptides with enhanced binding to Bcl-xL gain permeabilizing activity. NoxaBH3 
peptides containing substitutions of charge (K35E), hydrophobicity (F32I), or both (K35E and F32I; Fig. S1; Chen et al., 2005) were compared with wild-
type peptide for the ability to permeabilize mitochondria as in C.JCB • VOLUME 177 • NUMBER 2 • 2007  280
Specifi  cally, sensitizer BH3 peptides such as Bad and Puma 
were reported not to permeabilize MLM (Bim and Bid peptides 
were not tested). Because Certo et al. (2006) apparently incu-
bated the mitochondria at room temperature (Letai et al., 2002), 
whereas we used 37°C, we tested the effect of temperature on 
MLM permeabilization elicited by several peptides and by tBid 
(Fig. 2). Importantly, at room temperature (22°C), Puma and 
Bad released very little cytochrome c, which is consistent with 
the study by Certo et al. (2006), but neither did the Bim or Bid 
peptides. In contrast, all four peptides provoked release at 37°C. 
At 30 and 37°C, the Puma peptide was essentially as effective as 
the Bim or Bid peptides, whereas the Bad peptide was weaker, 
which is consistent with its more restricted binding pattern for 
prosurvival proteins (Figs. 1 B and S1). Moreover, tBid was 
several times more active at the higher temperatures than at 
room temperature. Thus, the release of cytochrome c from 
MLM involves a temperature-dependent step, but their permea-
bilization is not confi  ned to Bim and Bid (see Discussion).
Four prosurvival proteins block 
tBid-induced mitochondrial permeability
We next explored how mitochondrial permeability was affected 
by the addition of recombinant prosurvival proteins. Bcl-xL, 
Bcl-w, Mcl-1, and BHRF1 (the Bcl-2 homologue from Epstein-
Barr virus) were selected because they have distinct binding 
profi  les for BH3 peptides and/or Bak. Bcl-xL and Bcl-w bind 
Bad but not Noxa, whereas Mcl-1 binds Noxa but not Bad 
(Chen et al., 2005), and BHRF1 binds neither Bad nor Noxa 
(Figs. 1 B and S1 B; unpublished data). Furthermore, whereas 
both Bcl-xL and Mcl-1 bind Bak, Bcl-w does so only very poorly 
(Willis et al., 2005). For Bcl-w, Mcl-1, and BHRF1, we had to 
use forms lacking a portion of the C-terminal hydrophobic seg-
ment because the full-length recombinant proteins were poorly 
soluble, whereas the truncated molecules are well-behaved pro-
teins that retain full BH3 binding (Hinds, M., and P. Czabotar, 
personal communication; Hinds et al., 2003; Day et al., 2005).
All four prosurvival proteins could block the tBid-induced 
permeability of XEM, and all except Bcl-w protected MLM 
(Fig. 3 A). The failure of Bcl-w to protect MLM is consistent 
with its poor ability to bind to Bak or to protect mouse cells 
from Bak-mediated apoptosis (Willis et al., 2005). The permea-
bilization of MLM is Bak dependent, as they contain Bak but no 
detectable Bax, and MLM from bak
−/− mice are insensitive to 
tBid or BH3 peptides (Fig. S3, D–F; Letai et al., 2002). In con-
trast, XEM permeability apparently is not mediated solely via 
Bak because XEM are protected by the addition of either Bcl-w 
(Fig. 3 A) or Bcl-2 (Kluck et al., 1997), neither of which can 
bind Bak appreciably or protect cells from Bak-mediated apopto-
sis (Willis et al., 2005). Because Xenopus possesses homologues 
of Bax as well as Bak (Aouacheria et al., 2005) and mitochondria 
of undifferentiated cells can contain high levels of Bax (Polster 
et al., 2003), we surmise that XEM permeabilization is not solely 
Bak dependent because of resident Bax (or Bok).
Although Bcl-xL at low concentrations ( 20 nM) pro-
tected both types of mitochondria, 10–30-fold higher concentra-
tions of the other prosurvival proteins were required. Their lower 
potency can be attributed largely to their C-terminal truncation, 
as Bcl-xL∆C24 was around 10–30 times less active than full-
length Bcl-xL (Fig. 3 B). The cytosolic conformer of the Bcl-w 
prosurvival protein has its hydrophobic C-terminal domain 
tucked into the hydrophobic binding groove, but this domain 
can evert to insert into intracellular membranes (Hinds et al., 
2003). Removal of its C-terminal residues facilitates binding of 
BH3-only proteins to the hydrophobic groove but decreases at-
tachment to mitochondria (Hinds et al., 2003; Wilson-Annan 
et al., 2003). As each prosurvival protein contains a hydrophobic 
C-terminal domain, the much stronger protection observed with 
full-length Bcl-xL (Fig. 3 B) probably refl  ects its enhanced abil-
ity to locate to the mitochondrial outer membrane.
The failure of Bcl-w to protect MLM but not XEM from 
tBid (Fig. 3 A) may refl  ect its poor affi  nity for Bak. Interest-
ingly, high concentrations of Bcl-w did augment the protection 
from tBid conveyed by Bcl-xL if Bcl-xL was at a concentration 
that was only partially protective (Fig. 3 C, 10 nM Bcl-xL in the 
9th, 12th, and 15th lanes). This limited degree of protection 
may be caused by Bcl-w sequestration of tBid or by a slight 
ability of Bcl-w to bind Bak (Willis et al., 2005). Similarly, a 
recent report that high concentrations of Bcl-w could block the 
tBid-induced permeabilization of MLM (Certo et al., 2006) 
might be a result of the sequestration of the low concentration 
of tBid added (which gave only 50% cytochrome c release). 
Together, these fi  ndings suggest that prosurvival proteins do not 
protect mitochondria simply by sequestering BH3 ligands (see 
Discussion). Presumably, Bcl-w can protect the XEM (Fig. 3 A) 
by engaging a protein present specifi  cally in those mitochondria 
(perhaps Xenopus Bax).
Mcl-1 and BHRF1 can protect 
mitochondria without sequestering 
the challenging BH3 peptide
We assessed how the known affi  nities of these prosurvival pro-
teins for each BH3 peptide (Figs. 1 B and S1 B; Chen et al., 
2005) correlated with their ability to block the permeabilization 
elicited by that peptide. If a prosurvival protein acted solely by 
sequestering the BH3 peptide, protection would be minimal 
where interaction with the peptide is weak. To test this, XEM 
Figure 2.  Permeabilization of MLM is temperature dependent. MLM were 
incubated with the indicated BH3 peptides (left) or tBid (right) for 2 h at 
different temperatures as indicated. Cytochrome c release was assessed by 
Western blotting as in Fig. 1 C. S/N, supernatant; Mito, mitochondrial pellet.BCL-2 PROTEIN INTERACTIONS AT MITOCHONDRIA • UREN ET AL.  281
were preincubated with increasing concentrations of a pro-
survival protein and were challenged with the BH3 peptides 
shown (Fig. 1 C) to be active (Fig. 4 A and Fig. S4, available at 
http://www.jcb.org/cgi/content/full/jcb.200606065/DC1; and not 
depicted). Notably, although Mcl-1 does not bind the Bad BH3 
peptide (Chen et al., 2005), it effi  ciently blocked BadBH3-
induced permeability. Likewise, despite the poor binding affi  nity 
of BHRF1 for the Bad, Bmf, and Hrk BH3 peptides (Fig. S1 B), 
BHRF1 effi  ciently blocked cytochrome c release from XEM by 
each of them (Figs. 4 A and S4). Mcl-1 and BHRF1 also blocked 
the permeabilizing effect of these BH3 peptides on MLM (Fig. 
4 B). A model of how MLM are permeabilized by Bad and 
  protected by Mcl-1 is shown in Fig. 4 C.
In these cases, Mcl-1 and BHRF1 cannot protect mitochon-
dria merely by sequestering the added BH3 peptide. Indeed, 
close examination of further results with XEM (Fig. S4) suggests 
that Mcl-1 and BHRF1 are actually more effective at blocking 
the activity of BH3 peptides that they cannot bind. For example, 
Mcl-1 protected XEM better from the Bad than from the Bim or 
Puma peptides, and BHRF1 protected XEM better from the Bad, 
Bmf, or Hrk peptides than from the Bim or Puma peptides. To-
gether, these fi  ndings demonstrate that prosurvival function does 
not rely on the sequestration of BH3 ligands. Instead, the peptides 
that bind the prosurvival protein simply reduce its ability to bind 
its true target. As argued above for Bcl-xL and Bcl-w (Fig. 3), 
Mcl-1 and BHRF1 must be acting on a component of the 
isolated mitochondria. Because both Mcl-1 and Bcl-xL can bind 
Bak (Cuconati et al., 2003; Willis et al., 2005) and both can pre-
vent Bak-mediated apoptosis (Nijhawan et al., 2003; Willis et al., 
2005), Bak is almost certainly their MLM target. How BHRF1 
protects from Bak-mediated apoptosis is currently uncertain.
A proponent of the direct activation model might argue 
that the sensitizer peptides induce permeabilization in these 
experiments by releasing endogenous Bim or tBid putatively 
bound to prosurvival proteins on the mitochondria. Contrary to 
that notion, we have reported recently that sensitizer BH3 pep-
tides can effi  ciently induce the permeabilization of mitochon-
dria derived from bim
−/−bid
−/− mice (Willis et al., 2007). 
Moreover, Fig. 4 D shows that the absence of both Bim and Bid 
did not affect the ability of prosurvival proteins to protect the 
mitochondria from sensitizer peptides. In accord with this   result, 
sensitive Western blots have failed to reveal any form of Bim, 
Bid, or Puma in wild-type MLM (Fig. S3, G–I). Thus, none of 
the putative activator BH3-only proteins appears to be required 
to induce permeabilization.
Binding of NoxaBH3 to Mcl-1 
or of BadBH3 to Bcl-xL 
permeabilizes mitochondria
To explore whether the binding profi  les of BH3 peptides to pro-
survival proteins regulate mitochondrial permeability, we estab-
lished mitochondrial incubations in which the dominant acting 
Figure 3.  Four prosurvival proteins block tBid-induced 
permeabilization of isolated mitochondria. (A) Mitochondria 
from XEM or MLM were preincubated with recombinant pro-
survival proteins at the indicated concentrations and supple-
mented with tBid for a further 2 h. Supernatant and pellets 
were examined by Western blotting for cytochrome c (in the 
MLM experiment, only half of the supernatant samples were 
loaded compared with the pellets). (B) C-terminal truncation of 
hBcl-xL decreases potency. MLM were incubated as in A with 
full-length hBcl-xL, a C-terminally truncated form (hBcl-xL∆C24), 
or with Xenopus Bcl-xL∆C23. (C) High concentrations of Bcl-w 
can complement Bcl-xL–mediated protection. MLM were incu-
bated as in A with Bcl-w∆C10, Bcl-xL, or both before expo-
sure to tBid at the indicated concentrations. S/N, supernatant; 
Mito, mitochondrial pellet.JCB • VOLUME 177 • NUMBER 2 • 2007  282
prosurvival protein was either Bcl-xL or Mcl-1 and exposed the 
mitochondria to either the BadBH3 peptide (to neutralize Bcl-xL) 
or the Noxa one (to neutralize Mcl-1). We reasoned that only 
BH3 peptides that could bind to the governing prosurvival pro-
tein and, thus, prevent it from engaging its mitochondrial target 
would induce permeability. Bcl-xL–protected mitochondria were 
provided by XEM supplemented with tBid and Bcl-xL, whereas 
the Mcl-1–protected mitochondria were XEM supplemented 
with tBid and Mcl-1. Titrations showed that in these mixtures, 
either 30 nM Bcl-xL or 300 nM Mcl-1 protected against at least 
20 nM tBid (Fig. 5 A). Both types of supplemented XEM 
  remained intact unless specifi  c BH3 peptides were added.
Notably, although NoxaBH3 did not permeabilize unsup-
plemented XEM (Fig. 1 C), it readily sensitized the Mcl-1–
protected XEM to tBid (Fig. 5 A). Conversely, BadBH3 could 
permeabilize normal XEM but not the Mcl-1–protected XEM 
(Fig. 5 A). Thus, in these experiments, NoxaBH3 initiated per-
meability by directly binding and inactivating Mcl-1, whereas 
BadBH3 was inactive because it cannot bind Mcl-1. Conversely, 
the Bcl-xL–protected XEM were susceptible to BadBH3 but not 
NoxaBH3. Furthermore, MLM supplemented in the same way 
as XEM gave equivalent results: Noxa but not Bad sensitized 
MLM protected by Mcl-1 to tBid, whereas Bad but not Noxa 
could disrupt MLM guarded by Bcl-xL (Fig. 5 B) or by Bcl-
xL∆C24 (not depicted). In contrast to Bad and Noxa, the Bim 
and Puma peptides, which can bind to both Mcl-1 and Bcl-xL, 
induced permeability in MLM protected by either Mcl-1 or Bcl-xL 
(Fig. 5 B, bottom).
Thus, the contrasting behavior of the Bad and Nox-
aBH3 peptides with either XEM or MLM confi  rms that bind-
ing of BH3 ligands to specifi  c prosurvival proteins is the 
major route to the disruption of mitochondria. In these ex-
periments, it appears unlikely that tBid is acting as a direct 
activator of Bak because Fig. S5 (available at http://www
.jcb.org/cgi/content/full/jcb.200606065/DC1) shows that the 
BadBH3 peptide, which does not associate with Bak, could 
Figure 4.  Mcl-1 and BHRF1 can even block the action of 
those BH3 peptides that they cannot bind. (A) Permeability of 
XEM induced by BadBH3 is efﬁ  ciently blocked by prosurvival 
proteins that cannot bind Bad. XEM were preincubated for 
20 min with the indicated concentrations of Mcl-1∆C11 or 
BHRF1∆C16 and were supplemented with mBadBH3 peptide 
for a further 2 h. Supernatant and pellets were then examined 
for cytochrome c by Western blotting. Similar experiments 
involving Mcl-1 and BHRF1-mediated protection from 
hBad, Bmf, Hrk, Bim, and Puma BH3 peptides are shown in 
Fig. S4 (available at http://www.jcb.org/cgi/content/full/
jcb.200606065/DC1. (B) Permeability of MLM induced by 
mBad, Bmf, and Hrk BH3 peptides is efﬁ  ciently blocked by 
Mcl-1 and BHRF1. MLM were incubated as in A with the indi-
cated combinations of prosurvival proteins and BH3 peptides. 
(C) Model of how MLM are permeabilized by Bad (top) and 
protected by Mcl-1 (bottom). For simplicity, all of the Bak in 
the healthy cell is depicted as bound to Bcl-xL, but the indirect 
activation model postulates that only a proportion of the Bak 
molecules is in that form. (D) Permeabilization of mitochondria 
lacking both Bim and Bid by the sensitizer BH3 peptides Bad 
and Bmf. In an experiment like that in B, the absence of both 
of these putative activators does not prevent cytochrome c 
release or affect the protection conveyed by Mcl-1 and 
BHRF1, which do not bind Bad or Bmf. S/N, supernatant; 
Mito, mitochondrial pellet; Wt, wild type.BCL-2 PROTEIN INTERACTIONS AT MITOCHONDRIA • UREN ET AL.  283
substitute for tBid in an experiment equivalent to that in Fig. 
5 A. Instead, tBid probably is required to permeabilize mito-
chondria in Fig. 5 because it, together with the added BH3 
peptide, can target all of the relevant prosurvival proteins, 
whether endogenous or added.
BH3 peptides that can bind Bcl-w 
or BHRF1 overcome their protection
Because only particular BH3 peptides could neutralize Mcl-1 
and Bcl-xL, we asked whether Bcl-w and BHRF1 behaved simi-
larly by establishing mitochondrial mixtures in which each was 
the dominant prosurvival protein. Again, only specifi  c BH3 
peptides triggered permeabilization (Fig. 5 C). Because Bad or 
Puma but not Noxa can bind to Bcl-w (Figs. 1 B and S1 B), 
Bcl-w–mediated protection was overcome only by the Bad 
or Puma peptide. Similarly, BHRF1-mediated protection was 
overcome by the Puma but not the Bad or Noxa peptides, which 
is consistent with the ability of Puma but not Bad or Noxa to 
bind to BHRF1 (Figs. 1 B and S1 B). Thus, the binding of spe-
cifi  c BH3 peptides to each prosurvival protein was required 
to overcome the mitochondrial protection bestowed by that 
prosurvival protein.
Noxa and Bad provide complementary 
permeability function
Complementation between Noxa and BadBH3 domains has 
been observed in killing assays with cells (mouse embryonic 
fi  broblasts) that express both Bcl-xL–like and Mcl-1–like proteins 
(Chen et al., 2005; Willis et al., 2005). Our aforementioned 
fi  ndings suggested that mitochondria protected by both types 
of prosurvival proteins would require both the Noxa and Bad 
peptides to induce permeability. To test their complementarity, 
we established mitochondria protected by both Bcl-xL–like and 
Mcl-1 proteins. We reasoned that XEM predominantly con-
tained only Bcl-xL–like prosurvival proteins because BadBH3 
readily induced their permeabilization (Figs. 1 C and 4 A). 
Thus, by simply supplementing XEM with Mcl-1, we generated 
dual-protected mitochondria.
As predicted, neither the Bad nor Noxa peptide alone 
could permeabilize the dual-protected mitochondria even at 
high concentrations (30 μM), whereas the combination was ac-
tive even at 1 μM (Fig. 6). Presumably, BadBH3 bound the en-
dogenous Bcl-xL–like proteins (as in Figs. 1 C and 4 A), whereas 
NoxaBH3 neutralized the exogenous Mcl-1 (as in Fig. 5 A). As 
the permeabilization in these experiments did not involve the 
Figure 5. Speciﬁ  c binding of BH3 peptides to 
prosurvival proteins results in mitochondrial 
permeability.  (A and B) Mcl-1– or Bcl-xL–
  mediated protection can be overcome only by 
BH3 peptides that bind that prosurvival protein. 
XEM (A) or MLM (B) were preincubated with 
either no addition or with Mcl-1∆C11 or Bcl-xL 
and were supplemented with tBid together with 
Bad (human in A and mouse in B), Noxa, Bim, 
or Puma peptides as indicated for a further 2 h. 
(C) Speciﬁ  c binding of BH3 peptides to BHRF1 
and Bcl-w results in mitochondrial permeabil-
ity. XEM were preincubated with no addition, 
BHRF1∆C16, or Bcl-w∆C10 and supplemented 
with tBid together with hBad, Noxa, or Puma 
peptides as indicated for a further 2 h. Super-
natant and pellets were examined by Western 
blotting for cytochrome c. S/N, supernatant; 
Mito, mitochondrial pellet.JCB • VOLUME 177 • NUMBER 2 • 2007  284
addition of tBid (or indeed any other component), it appears 
that Bax/Bak activity can be triggered simply by inactivating 
both the Mcl-1 and Bcl-xL–like proteins. It is also noteworthy 
that the endogenous Bcl-xL–like proteins present in XEM be-
haved similarly to added recombinant Bcl-xL (Fig. 5), support-
ing the physiological relevance of those experiments. Thus, the 
permeabilization of mitochondria protected by both Bcl-xL–like 
and Mcl-1–like prosurvival proteins requires the neutralization 
of both types of guardians, as found for apoptosis in cells (Willis 
et al., 2005, 2007).
Bak association with Mcl-1 and Bcl-xL 
is disrupted by the speciﬁ  c binding 
of BH3-only reagents
We next examined whether BH3 peptide–initiated mitochon-
drial permeabilization was caused by the disruption of Bak 
binding to prosurvival proteins. As in Fig. 5 B, MLM were in-
cubated with tBid and either Mcl-1 or Bcl-xL together with Bad, 
Noxa, or BimBH3 peptides (Fig. 7 A). The mitochondrial pel-
lets were then examined for the binding of Bak to Mcl-1 or Bcl-xL 
by coimmunoprecipitation. In the absence of BH3 peptides, 
Bak immunoprecipitated with Mcl-1 and Bcl-xL, whereas in the 
presence of Bim peptide, Bak failed to associate with either 
Mcl-1 or Bcl-xL. In contrast, Noxa specifi  cally interfered with 
Bak binding to Mcl-1, whereas Bad interfered with its binding 
to Bcl-xL. Importantly, in each case, the failure of Bak to bind 
its guardian correlated with the mitochondrial release of cyto-
chrome c. Thus, in these mitochondrial incubations, specifi  c 
binding of BH3 peptides to prosurvival proteins blocks the 
  sequestration of Bak, allowing it to permeabilize mitochondria.
Interestingly, the binding of Noxa or Bim to Mcl-1 (which 
lacks 11 hydrophobic C-terminal residues) reduced its associa-
tion with mitochondria, as indicated by the lower Mcl-1 levels 
immunoprecipitated from the mitochondrial pellet (Fig. 7 A, 
compare the third and fourth lanes with the fi  rst and second 
lanes). The Bad or Bim peptide did not reduce the association of 
full-length Bcl-xL with mitochondria, presumably because its 
hydrophobic C terminus can insert into the mitochondrial outer 
membrane independent of binding to Bak.
The specifi  c effects of Bad and Noxa on Bak association 
with prosurvival proteins were also observed in whole cell ly-
sates (Fig. 7 B). HA-tagged Bad or Noxa were stably expressed 
in HeLa cells, which contain functionally relevant levels of the 
two Bak guards Mcl-1 and Bcl-xL. As previously observed for 
fi  broblasts (Chen et al., 2005; Willis et al., 2005), the cells re-
mained viable because either Mcl-1 or Bcl-xL is suffi  cient to se-
quester Bak. Notably, in the Bad-expressing cells, Bcl-xL could 
bind Bad but could no longer bind Bak (Fig. 7 B, second lane), 
whereas in Noxa-expressing cells, Mcl-1 could bind Noxa but 
could not bind Bak (Fig. 7 B, sixth lane). Interestingly, the 
  inability of one prosurvival guardian to bind Bak resulted in 
higher levels of Bak associating with the other guardian: for ex-
ample, Noxa targeting of Mcl-1 lead to a higher Bak association 
with Bcl-xL (Fig. 7 B, third lane) and vice versa for Bad (Fig. 7 B, 
fi  fth lane). This suggests that the Bak released from either of its 
two guards is bound by the other guard.
Discussion
We have explored how interactions between members of the 
Bcl-2 family affect the integrity of the mitochondrial outer 
membrane. By relying on the Bak/Bax present in isolated mito-
chondria, we avoided introducing supraphysiological levels of 
these proteins, and, by studying MLM, which only contain Bak, 
we identifi  ed  Bak-specifi   c pathways. We analyzed how the 
known binding interactions of four prosurvival proteins with 
Bak (Willis et al., 2005) or the BH3 peptides from eight BH3-
only proteins (Chen et al., 2005) correlate with mitochondrial 
permeabilization. The impact of each BH3 reagent on permea-
bility correlated well with its known effect on apoptosis in in-
tact cells. Notably, certain prosurvival proteins could prevent 
permeabilization by BH3 peptides that they do not bind. This 
suggests that prosurvival proteins convey protection primarily 
by associating with mitochondrial components such as Bak. 
However, specifi  c interactions between BH3-only reagents and 
prosurvival proteins did result in mitochondrial permeability. 
The fi  ndings support a model of apoptotic mitochondrial per-
meability (Willis et al., 2005) in which BH3-only proteins inter-
act with specifi  c subsets of prosurvival proteins, blocking their 
binding to endogenous mitochondrial targets: Bak in the MLM 
but perhaps also Bax in the XEM (Fig. 1 A, right).
Prosurvival proteins protect mitochondria 
primarily by engaging Bak and perhaps Bax
In accord with a previous study showing that added Bcl-2 could 
protect XEM (Kluck et al., 1997), each of the four prosurvival 
proteins tested here protected these mitochondria from pro-
apoptotic permeability. In several cases, the protection must be 
mediated by interactions with a mitochondrial component 
rather than by simply sequestering the challenging BH3 re-
agent. For example, Mcl-1 and BHRF1 could each block per-
meabilization by BH3 peptides that they do not bind (Figs. 4 
and S4). In MLM, the target for Mcl-1 as well as Bcl-xL is 
  almost certainly Bak, as both bind Bak and both protect cells 
Figure 6.  Complementation between Bad and Noxa BH3 
peptides is needed to permeabilize mitochondria protected by 
both Mcl-1 and Bcl-xL–like prosurvival proteins. XEM (which 
functional experiments indicate contain predominantly Bcl-xL–
like prosurvival proteins) were preincubated with 300 nM Mcl-
1∆C11 to produce dual-protected mitochondria. Noxa and 
mBadBH3 peptides were then added alone or in combination 
as indicated. Supernatant and pellets were examined by 
Western blotting for cytochrome c. Similar results were ob-
tained with MLM (not depicted). Note that unlike in Fig. 5, tBid 
is not included. S/N, supernatant; Mito, mitochondrial pellet.BCL-2 PROTEIN INTERACTIONS AT MITOCHONDRIA • UREN ET AL.  285
from Bak-mediated apoptosis (Nijhawan et al., 2003; Willis et al., 
2005). Because BHRF1 exhibited a similar ability to protect 
MLM (Fig. 3), it probably also targets Bak, although whether 
this involves direct interaction is under investigation. On the 
other hand, Bcl-w may protect largely via its ability to associate 
with Bax because it could effi  ciently protect XEM from tBid 
and Bid, Bad, Hrk, and Bmf BH3 peptides (Figs. 3 A, 4 A, and 
5 C; and not depicted). It also effi  ciently binds to Bax (Willis 
et al., 2007) but was highly ineffi  cient in blocking the Bak-
mediated permeability of MLM (Fig. 3) and does not bind appre-
ciably to Bak (Willis et al., 2005).
Further evidence that Bak is the MLM component guarded 
by Mcl-1 and Bcl-xL was obtained from coimmunoprecipitation 
experiments. In lysates of MLM, Bak associated with both pro-
survival guardians, but, in the presence of BH3 peptides that 
could engage the prosurvival guardian, Bak was not bound, and 
MLM became permeabilized (Fig. 7 A). The disruption of Bak 
binding to prosurvival proteins was also observed in lysates of 
HeLa cells expressing either Bad or Noxa (Fig. 7 B). It should 
be noted that in these experiments, Triton X-100 that was in-
cluded in the lysis buffer to solubilize the membrane-integrated 
Bak could change Bak conformation and increase Bak binding 
to prosurvival proteins (our unpublished data), as observed for 
Bax (Hsu and Youle, 1998). Thus, in situ, a much smaller frac-
tion of Bak may be bound to Mcl-1 and Bcl-xL. This appears to 
be true for HeLa cells because in the presence of the zwitter-
ionic detergent CHAPS, less Bak coimmunoprecipitated with 
Mcl-1 and Bcl-xL (unpublished data). The issue of what propor-
tion of Bak molecules associates with the prosurvival proteins 
will require more detailed study, including an analysis of how 
the conformation of Bak and its association with prosurvival 
proteins is affected by detergents. Conceivably, a small propor-
tion of Bak (or Bax) is already primed in healthy cells seques-
tered by prosurvival proteins. Alternatively, Bak/Bax become 
primed at an early stage of apoptotic signaling by changes such 
as posttranslational modifi  cation rather than by direct binding 
of BH3-only proteins and initiate permeabilization of the mito-
chondria if their prosurvival antagonists have been engaged by 
the BH3-only proteins.
Interactions between speciﬁ  c BH3 
peptides and prosurvival proteins 
induce mitochondrial permeability
By establishing mitochondrial incubations in which the govern-
ing prosurvival protein was Bcl-xL, Mcl-1, Bcl-w, or BHRF1, 
we showed that permeabilization of these mitochondria corre-
lated with the ability of the challenging BH3 peptide to bind 
that guardian. This was most evident in the case of interactions 
of the BadBH3 peptide with Bcl-xL or Bcl-w and of the Noxa
BH3 peptide with Mcl-1 (Figs. 5 and 7 A), but a correlation was 
observed with every BH3-only reagent. Indeed, both Bad and 
NoxaBH3 peptides were required to permeabilize mitochondria 
protected by both the Bcl-xL and Mcl-1 subsets of prosurvival 
proteins (Fig. 6).
Thus, our fi  ndings suggest that the predominant conse-
quence of binding between a BH3-only and a prosurvival pro-
tein is not sequestration of the BH3-only protein but inactivation 
of the prosurvival protein, preventing its interaction with its 
critical target. As proposed from studies on the apoptosis of 
fi  broblasts (Chen et al., 2005; Willis et al., 2005), the experiments 
involving MLM demonstrated that engagement of Mcl-1– and 
Bcl-xL–like proteins initiates Bak-mediated mitochondrial per-
meability (Figs. 5 B and 7 A). The same may well hold for Bax-
mediated permeability, as BH3 ligands of Bcl-w (such as Bad) 
permeabilized XEM (Fig. 5 C), a process likely mediated by 
Bax as well as Bak (see Results). Thus, each of the tested pro-
survival proteins, including the viral BHRF1 protein, conferred 
upon mitochondria a highly specifi  c pattern of susceptibility to 
permeabilization by BH3 reagents. The permeabilization of un-
supplemented MLM by Bad, for example, did not require Noxa, 
as might have been expected from the need for both to kill 
mouse embryonic fi  broblasts (Willis et al., 2005). We think that 
difference is caused by a far lower level of the Noxa target Mcl-1 
in the MLM than in the fi  broblasts (Fig. 1 D). Our conclusion 
that the MLM are protected primarily by Bcl-xL is consistent 
Figure 7. Speciﬁ  c binding of BH3 ligands to Mcl-1 and Bcl-xL disrupts 
their binding of Bak. (A) The ability of BH3 peptides to permeabilize MLM 
corresponds with their disruption of Bak binding to Mcl-1 or Bcl-xL. MLM 
were treated as in Fig. 5 B, and aliquots of the supernatant and pellet frac-
tions were analyzed by Western blotting for cytochrome c and Bak (top 
three panels). The remaining mitochondrial pellet fractions underwent 
immunoprecipitation for Mcl-1 or Bcl-xL before Western blotting for Bak, 
Mcl-1, and Bcl-xL (bottom three panels). The Noxa BH3 peptide used was 
K35E. (B) Bad and Noxa expressed in HeLa cells compete with Bak for as-
sociation with Mcl-1 and Bcl-xL. Mcl-1 or Bcl-xL was immunoprecipitated 
from HeLa cells stably expressing HA-tagged Bad or HA-tagged Noxa. 
Immunoprecipitates and cell lysates were examined by Western blotting for 
Bak, Mcl-1, Bcl-xL, and HA. The asterisk marks the IgG light chain, which 
runs just above Bcl-xL. IP, immunoprecipitation; S/N, supernatant; Mito, 
mitochondrial pellet.JCB • VOLUME 177 • NUMBER 2 • 2007  286
with the fi  nding that conditional deletion of the bcl-xL gene in 
hepatocytes provokes chronic spontaneous apoptosis (Takehara 
et al., 2004).
Recently, another study reported that sensitizer BH3 pep-
tides such as Bad and Puma were unable to induce cytochrome c 
release from MLM (Certo et al., 2006), whereas we have repro-
ducibly found the permeabilization of MLM by fi  ve such pep-
tides (Bad, Puma, Bmf, Bik, and Hrk) as well as by Bim and 
Bid (Figs. 1 C, 2, 4 B, and S2). These apparent discrepancies 
probably have two sources. First, most of the peptides used in 
that study were 20 mers, whereas those used here were 24–26 
residues long. Longer peptides (with a few exceptions) bind 
more tightly to the prosurvival proteins, as can be seen with the 
two Bid peptides we have tested (Fig. S1). Indeed, the BimBH3 
26 mer used here binds as avidly to Bcl-w as a much longer Bim 
polypeptide (Wilson-Annan et al., 2003), which is consistent 
with evidence from the Bim–Bcl-xL 3D structure that the BH3 
domain is at least 26 residues long (Liu et al., 2003). Second, 
and perhaps more importantly, the mitochondria in that study 
were incubated for only 45 min at room temperature, whereas 
the MLM permeabilization in the current study involved a 2-h 
incubation at 37°C. For MLM, we showed that the higher tem-
perature was critical for the release of cytochrome c by the pep-
tides and notably enhanced that by tBid (Fig. 2). Because the 
permeabilization probably involves multiple steps—binding of 
the BH3 domain to the resident prosurvival proteins, release of 
Bak from them, oligomerization of Bak, alteration of the mem-
brane, and egress of cytochrome c—it is not surprising that one 
or more of these steps would be temperature dependent.
MLM permeabilization does not rely 
on Bid, Bim, or Puma
In the direct activation model for the control of apoptosis (Fig. 
1 A), the activation of Bax and Bak is proposed to require their 
direct engagement by Bid or Bim (Letai et al., 2002; Kuwana 
et al., 2005; Certo et al., 2006; Kim et al., 2006). However, com-
pared with the high affi  nity binding of BH3 domains to pro-
survival proteins (Chen et al., 2005), the evidence for such 
associations with Bax/Bak remains tenuous (Willis and Adams, 
2005). In this model, Bid, Bim, or Puma (Cartron et al., 2004) 
would be sequestered in the mitochondria by prosurvival family 
members until freed to activate Bax/Bak by a sensitizer BH3 
domain. However, Bid, Bim, or Puma does not appear to play a 
direct activator role in our MLM experiments, as Western blot 
experiments did not reveal any form of Bid, Bim, or Puma in 
wild-type MLM (Fig. S3), and MLM isolated from mice lack-
ing both Bim and Bid are permeabilized by sensitizer BH3 pep-
tides (Willis et al., 2007). Furthermore, despite the high affi  nity 
of Bcl-w for each of these three BH3 ligands, its inability to 
protect MLM (Fig. 3) argues that none of these three BH3-only 
proteins are required for Bak activation. Finally, Bid, Bim, 
and Puma do not appear to bind Bak or be required for Bak-
mediated apoptosis (Willis et al., 2007). Together, these results 
appear inconsistent with the direct activation model (Fig. 1 A, 
left), at least for Bak.
In conclusion, our results favor the view that BH3-only 
proteins function primarily, if not exclusively, as antagonists of 
specifi  c subsets of their prosurvival relatives and that these 
death ligands induce apoptosis by unleashing Bak or Bax from 
control by the prosurvival proteins rather than by direct engage-
ment of Bak/Bax (Chen et al., 2005; Willis et al., 2005, 2007). 
However, further studies are required to establish what propor-
tion of Bak and Bax are bound to the prosurvival proteins within 
healthy cells and to clarify what induces their changed confor-
mation and oligomerization (Adams and Cory, 2007).
Materials and methods
Materials
The BH3 peptides, most of which were described previously (Chen et al., 
2005), were 24–34 residues long (Fig. S1 A). Caspase-8–cleaved human 
Bid (tBid) and human Bcl-xL were produced as previously described (Kluck 
et al., 1999). Human Bcl-wA128E∆C10 and mouse Mcl-1∆N151∆C11, 
which were also produced as described previously (Hinds et al., 2003; 
Day et al., 2005), contained ﬁ  ve additional N-terminal residues (GPLGS) 
as a result of cloning. Recombinant BHRF1∆C16 with N-terminal Flag tag 
was overexpressed in Escherichia coli BL21-Codon Plus cells from a 
pET11a vector (Novagen) and the protein puriﬁ  ed from cell lysates using 
Q-Sepharose ion-exchange chromatography followed by ammonium sul-
fate precipitation and Superdex G-75 gel ﬁ  ltration chromatography. Hu-
man Bcl-xL∆C24 was a gift from P. Czabotar (The Walter and Eliza Hall 
Institute, Melbourne, Victoria, Australia; produced as described previously 
[Chen et al., 2005]). Xenopus Bcl-xL∆C23 (xR11; a gift from J.R. Tata, 
National Institute for Medical Research, London, UK) was subcloned into 
pGEX-6P-3, and the protein was produced as described previously (Hinds 
et al., 2003; Day et al., 2005).
Isolation of mitochondria and incubation with BH3-only 
and prosurvival reagents
Heavy membrane fractions enriched for mitochondria were obtained from 
Xenopus eggs or from wild-type and bim
−/−bid
−/− mouse liver as previ-
ously described (Uren et al., 2005). For simplicity, these heavy membrane 
fractions are referred to here as XEM and MLM. For incubations with Bcl-2 
family proteins or peptides, 1 mg/ml XEM and MLM were each suspended 
in buffer (100 mM KCl, 2.5 mM MgCl2, 100 mM sucrose, 20 mM Hepes/
KOH, pH 7.5, and 1 mM DTT). Recombinant prosurvival proteins were 
added, and samples were incubated for 20 min at 22°C for XEM and at 
37°C for MLM before the addition of BH3-only reagents and further incu-
bation for 2 h (MLM were also incubated at 22 and 30°C in Fig. 2 as indi-
cated). After centrifugation at 10,000 g for 5 min at 4°C, the supernatant 
and pellet fractions were carefully separated. To assess mitochondrial per-
meability, each fraction was combined with loading buffer, and equivalent 
amounts (except as noted in Fig. 3 B) were analyzed by SDS-PAGE and 
Western blotting for cytochrome c (clone 7H8.2C12; BD Biosciences). For 
ease of viewing, the supernatant and pellet fractions were generally run on 
separate gels, which were then processed as matching pairs during each 
stage of electrophoresis, blotting, and detection and with no digital adjust-
ment of the scanned images.
Western blot analysis of Bcl-xL and Mcl-1 present in MLM
Aliquots of MLM (125 or 25 μg of protein) and whole cell lysates of mouse 
embryonic ﬁ  broblasts (30 or 50 μg of protein) were analyzed by Western 
blotting for the presence of Bcl-xL and Mcl-1 using antibodies raised against 
Bcl-xL (rabbit polyclonal; BD Biosciences) and mMcl-1 (rat monoclonal 
clone 19C4-15) followed by incubation with anti–rabbit and anti–rat HRP-
labeled secondary antibodies (Southern Biotechnology Associates, Inc.). 
The proteins were detected using ECL (GE Healthcare).
Immunoprecipitation
HeLa cells stably expressing Bad or Noxa were provided by J. Fletcher 
(The Walter and Eliza Hall Institute, Melbourne, Victoria, Australia). MLM 
and HeLa cell lysates were prepared in lysis buffer (20 mM Tris, pH 7.4, 
135 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, and 10% glycerol) contain-
ing 1% Triton X-100 and supplemented with Complete protease inhibitors 
(Roche). Immunoprecipitation was performed using anti–Mcl-1 (rat mono-
clonal clone 14CH-20) and anti–Bcl-xL (rat monoclonal clone 1C2; Willis 
et al., 2005), and immune complexes were captured with protein G–
Sepharose. Proteins were resolved by SDS-PAGE, transferred onto poly  vinyl-
idene diﬂ  uoride membranes, and detected by antibodies directed against Bak BCL-2 PROTEIN INTERACTIONS AT MITOCHONDRIA • UREN ET AL.  287
(rabbit polyclonal clone B5929; Sigma-Aldrich), Mcl-1 (rat mono  clonal 
clone 19C4-15), anti–Bcl-xL (mouse monoclonal clone 2H12; BD Biosci-
ences), or HA (mouse monoclonal clone 16B12; BAbCO). Secondary anti-
bodies used were anti–rabbit and anti–rat HRP-labeled antibodies 
(Southern Biotechnology Associates, Inc.) for Bak and Mcl-1, respectively, 
whereas Bcl-xL and HA were detected using a goat anti–mouse IgG Fcγ 
fragment–speciﬁ  c HRP conjugate (Jackson ImmunoResearch Laboratories).
Online supplemental material
Fig. S1 shows the sequence of each BH3 peptide used in this study and 
their binding afﬁ   nities for four prosurvival proteins. Fig. S2 shows that 
MLM permeabilization by sensitizer BH3 peptides correlates with Bak 
cross-linking. In Fig. S3, Western blots show that MLM contain readily de-
tectable levels of Bak, whereas Bax, Bcl-2, Bcl-w, A1, Bid, Bim, and Puma 
are undetectable. In Fig. S4, Mcl-1 and BHRF1 are most efﬁ  cient at block-
ing the BH3 peptides for which they have least afﬁ  nity. Fig. S5 shows that 
speciﬁ  c binding of BH3 peptides to Mcl-1 and Bcl-xL results in mitochon-
drial permeabilization (as in Fig. 5 A), even if BadBH3 replaces tBid as the 
initial permeabilizing agent. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200606065/DC1.
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